Medicine
Narcan 4 mg/0.1 mL nasal spray
Narcan 4 mg/0.1 mL nasal spray is a prescription medicine containing Naloxone for nasal use, marketed by Emergent Devices, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze or expose to excessive heat above 104°F (40°C). NARCAN Nasal…
Key facts
- Active ingredient (INN)
- Naloxone
- Brand
- Narcan
- Strength
- 4 mg/0.1 mL
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 2 vials
- Marketing authorisation holder
- Emergent Devices
- Manufacturers
- Emergent DevicesA-S Medication SolutionsProficient Rx
- Origin register
- US FDA, United States
- Storage
- Do not freeze or expose to excessive heat above 104°F (40°C). NARCAN Nasal Spray freezes at temperatures below 5°F (-15°C). Store below 77°F (25°C). Excursions permitted up to 104°F (40°C). However, NARCAN Nasal Spray may be thawed by allowing it to sit at room temperature for 15 minutes, and it may still be used if it has been thawed after being previously frozen.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AH04 Naloxone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 January 2017
- Identifiers
- RxCUI 1725059, 1725064DailyMed set ID 724df050-5332-4d0a-9a5f-17bf08a547e1, 76b5a1ce-e601-457c-ab35-43533bba4394, 139c30b9-5600-48f5-8610-0cacd2782398NDC 69547-353, 71205-528, 50090-2422Application NDA208411
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 vial, single-dose in 1 package / .1 mL in 1 vial, single-dose | 50090-2422-0 | A-S Medication Solutions | 24 January 2017 |
| 2 vial, single-dose in 1 package / .1 mL in 1 vial, single-dose | 71205-528-02 | Proficient Rx | 3 February 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Naloxone 4 mg/0.1 mL nasal spray.
Other strengths and forms of Naloxone
Clinical summary
Naloxone is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. MedsAcross supplies Naloxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaloxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Narcan prescribing information (Emergent Devices) · U.S. National Library of Medicine, DailyMed
- Nyxoid: European public assessment report (EPAR) · European Medicines Agency
Need Narcan 4 mg/0.1 mL nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.